Weerts E M, Ator N A, Grech D M, Griffiths R R
Behavioral Biology Research Center, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224-6823, USA.
J Pharmacol Exp Ther. 1998 Apr;285(1):41-53.
The current study examined behavioral effects and possible development of physical dependence after once-daily doses of zolpidem (0, 1.0, 3.2, 10.0, 32.0 mg/kg intragastrically [i.g.]) in three baboons. Each dose was administered for 17 days and then the dose was increased; the 32.0 mg/kg dose was administered for 27 days. Baboons had access to food pellets for 20 hr/day beginning 15 min after dosing. Each day, baboons were presented with a fine motor task. Observation sessions were conducted 1 hr after dosing on days 1, 10, 12 and 14 of each dose condition and after termination of drug dosing. On days 10 and 14 of each dose condition, vehicle and flumazenil (5 mg/kg i.m.) were administered, respectively. Zolpidem increased the number of pellets obtained by two of three baboons. Vomit and/or retch and grimace (signs believed to be indicative of abdominal discomfort) were observed in one or two baboons during all zolpidem dose conditions (1.0-32.0 mg/kg). Time to complete the fine motor task increased dose-dependently in all three baboons, and incoordination was observed during the task in two baboons at 10.0 and 32.0 mg/kg. Analysis of blood plasma showed that measurable levels of zolpidem were present 24 hr after dosing in all drug conditions. The signs of flumazenil-precipitated withdrawal were summarized on a 9-point scale. Scores ranged from 1 to 5 in the 1.0 mg/kg condition, from 2 to 5 in the 3.2 and 10.0 mg/kg conditions and from 4 to 6 in the 32.0 mg/kg condition. Signs that were considered intermediate in severity were observed. Specifically, tremor, jerk and/or rigidly braced posture was observed in one baboon at 1.0 mg/kg, two baboons at the next two doses and all three baboons at 32.0 mg/kg. Vomit and/or retch also occurred in two baboons at dose conditions above 1.0 mg/kg. Discontinuation of zolpidem dosing after 78 to 79 days resulted in mild withdrawal signs (e.g., number of pellets obtained were lower and number of 1-min intervals increased in which eyes were closed, or in which lying down, head lower than torso posture and/or withdrawn posture were observed) on the first day in two baboons. The peak withdrawal scores were 4 or 5 on days 5 to 10; two baboons vomited and/or retched and all three baboons showed tremor, jerk and/or rigidly braced posture. Thus, zolpidem produced physical dependence under once-daily dosing conditions, and the severity of the withdrawal syndrome can be characterized as intermediate.
本研究检测了三只狒狒每日一次经胃内(i.g.)给予不同剂量唑吡坦(0、1.0、3.2、10.0、32.0mg/kg)后的行为效应以及身体依赖性的可能发展情况。每个剂量给药17天,然后增加剂量;32.0mg/kg剂量给药27天。给药15分钟后,狒狒每天有20小时可获取食物颗粒。每天给狒狒安排一项精细运动任务。在每个剂量条件下的第1、10、12和14天以及停药后,于给药1小时后进行观察。在每个剂量条件下的第10和14天,分别给予溶媒和氟马西尼(5mg/kg,肌肉注射)。唑吡坦增加了三只狒狒中两只获取的食物颗粒数量。在所有唑吡坦剂量条件(1.0 - 32.0mg/kg)下,一只或两只狒狒出现呕吐和/或干呕及鬼脸(被认为是腹部不适的迹象)。在所有三只狒狒中,完成精细运动任务的时间呈剂量依赖性增加,在10.0和32.0mg/kg剂量时,两只狒狒在任务过程中出现不协调。血浆分析表明,在所有给药条件下,给药24小时后血浆中存在可测量水平的唑吡坦。氟马西尼诱发的戒断症状按9分制进行总结。在1.0mg/kg条件下,分数范围为1至5分;在3.2和10.0mg/kg条件下,分数范围为2至5分;在32.0mg/kg条件下,分数范围为4至6分。观察到了严重程度为中等的症状。具体而言,在1.0mg/kg时,一只狒狒出现震颤、抽搐和/或僵硬支撑姿势;在接下来的两个剂量时,两只狒狒出现这些症状;在32.0mg/kg时,所有三只狒狒均出现这些症状。在剂量高于1.0mg/kg时,两只狒狒也出现呕吐和/或干呕。在78至79天后停止唑吡坦给药,两只狒狒在第一天出现轻度戒断症状(例如,获取的食物颗粒数量减少,闭眼、躺下、头部低于躯干姿势和/或退缩姿势的1分钟间隔数量增加)。在第5至10天,戒断分数峰值为4或5分;两只狒狒呕吐和/或干呕,所有三只狒狒均出现震颤、抽搐和/或僵硬支撑姿势。因此,唑吡坦在每日一次给药条件下产生了身体依赖性,戒断综合征的严重程度可被描述为中等。